Skip to main content
CVS logo

CVS · CVS HEALTH Corp · Executive Compensation

Track CVS — free
Market Cap
$109.79B
Shares
1.28B
Volume · Nov 18 5.29M Avg daily vol (3M) 9.11M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
J. David Joyner $21,214,084
Prem S. Shah $13,379,210
Steven H. Nelson $11,587,110
Tilak Mandadi $10,977,716
Brian O. Newman $9,420,508
Thomas F. Cowhey $6,715,138
Fiscal 2024
Executive Total
Karen S. Lynch $23,431,466
J. David Joyner $17,808,792
Prem S. Shah $13,265,855
Tilak Mandadi $11,361,343
Thomas F. Cowhey $7,644,364
Heidi B. Capozzi $6,850,748
Fiscal 2023
Executive Total
Karen S. Lynch $21,615,034
Shawn M. Guertin $12,494,134
Samrat S. Khichi $11,886,503
Tilak Mandadi $8,881,845
Prem S. Shah $8,582,366
Thomas F. Cowhey $4,579,937
Fiscal 2022
Executive Total
Karen S. Lynch $21,317,055
Shawn M. Guertin $14,630,713
Tilak Mandadi $13,991,858
Alan Lotvin $10,983,750
Prem S. Shah $9,015,218
Fiscal 2021
Executive Total
Karen S. Lynch $20,388,412
Jonathan C. Roberts $15,354,581
Shawn M. Guertin $14,339,230
Alan Lotvin $11,011,560
Eva Boratto $9,885,690
Troyen A. Brennan $8,793,264
Larry Merlo $3,784,072
Fiscal 2020
Executive Total
Larry Merlo $23,043,822
Jonathan C. Roberts $13,001,212
Karen S. Lynch $11,307,916
Eva Boratto $8,921,153
Alan Lotvin $7,472,175
Fiscal 2019
Executive Total
Larry Merlo $36,451,749
Thomas M. Moriarty $23,154,934
Jonathan C. Roberts $15,048,380
Derica W. Rice $10,626,219
Eva Boratto $9,564,223
Fiscal 2018
Executive Total
Larry Merlo $21,939,098
Jonathan C. Roberts $16,066,968
Thomas M. Moriarty $10,983,856
Eva Boratto $6,972,421
Fiscal 2017
Executive Total
Larry Merlo $12,252,864
Jonathan C. Roberts $6,882,764
Thomas M. Moriarty $4,512,554

Executive changes

Person Change Filed
Teresa Heitsenrether Appointed 2026-08-17
Larry M. Robbins
“Mr. Robbins’ resignation was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.”
Resigned 2026-08-17
John E. Gallina Appointed 2026-03-19
Amy L. Compton-Phillips Appointed 2025-04-08
Brian O. Newman Appointed 2025-04-08
Doug Shulman Appointed 2024-11-18
Guy Sansone Appointed 2024-11-18
Larry Robbins Appointed 2024-11-18
Leslie Norwalk Appointed 2024-11-18
Doug Shulman Appointed 2024-11-18
Guy Sansone Appointed 2024-11-18
Larry Robbins Appointed 2024-11-18
Leslie Norwalk Appointed 2024-11-18
Steven H. Nelson Appointed 2024-11-06
Prem S. Shah Appointed 2024-11-06
J. David Joyner Appointed 2024-10-18
Roger N. Farah Appointed 2024-10-18
J. David Joyner Appointed 2024-10-18
Karen S. Lynch Resigned 2024-10-18
Karen S. Lynch Resigned 2024-10-18
J. David Joyner Appointed 2024-10-18
Mike Pykosz Appointed 2024-01-05
Thomas F. Cowhey Appointed 2024-01-05
Thomas F. Cowhey Appointed 2023-10-16
Michael F. Mahoney Appointed 2023-09-21

Leadership

Key facts CIK 64803 CUSIP 126650100 13F (30d) 1823 filings 1708 filers Visit website Investor relations